A Smart Baby Cradle

A small baby needs parents' attention for whole day and 7 days a week, which is impossible due to other priorities like house hold activities, official works and personal works. Day care centre or nanny is the two options available which involves lot of passion. We all live in a world where technologies are sournded all around us. The new generations of parents were raised up with this amazing technology. There are lots of things or items present on these earth that parents will buy to help them care for their baby (Cradle, Crib, Baby Monitor, etc.). So, there is a need for safe and secure place to take good care of the children2019;s need with minimum human intervention and care, which can be accomplished with the help of a 201C;Smart Baby Cradle201D;. A 201C;Smart Baby Cradle201D; provides parents a smart automatic cradle system which help these parents monitor and comfort the baby. The Smart Baby Cradle allows them to monitoring their babies, the cradle, play soothing music, even speak to the baby, observing the temperature of the infant, bed wet sensor which will caution the attendants for bunk wetting of the infant. The mother where so ever she is can have a look on the baby through camera inserted in the cradle. All the fittings are done through Arduino and PIR sensor. Additionally, we provide a predefined nutrition food chart to help baby remain healthy

Plasma Lipoprotein (a) levels in patients with untreated essential hypertension

Lipoprotein (a) [Lp (a)] is considered as a risk factor for vascular diseases, especially those associated with renal failure. Adequate studies have not been conducted on the lipoprotein (a) in essential hypertensive patients. There is a controversy on the mechanisms by which Lp (a) is associated with essential hypertension. It is unclear whether Lp (a) contributes to atherogenesis or to thrombogenesis or both. Recent studies suggest that Lp (a) can act as a marker for determining vascular or tissue injury. Reports on Indian population indicate elevated levels of Lp (a), together with other serum lipoproteins emphasizing an important role in Coronary Heart Disease (CHD) and peripheral atherosclerosis. In the present study we aimed to evaluate the relation between plasma levels of Lp (a) and the parameters of the lipid profile in a group of essential hypertensive patients, who are not receiving pharmacological treatment and with no clinical signs of associated pathologies or organ damage. A total of 37 essential hypertensive patients (27 men and 10 women) were compared with 50 controls (32 men and 18 women). It was observed that the hypertensive patients had higher plasma concentrations of Lp (a), Total Cholesterol (TC), Low-Density Lipoprotein-Cholesterol (LDL-C), and Triglycerides (TG) as compared to controls (P< 0.01). Hypertensive patients were also observed to have significantly low levels of High-Density Lipoprotein Cholesterol levels (HDL-C) as compared to controls (P<0.01). Only 14 hypertension patients and 4 controls had plasma concentrations of Lp (a) of over 30 mg/dl. Lp (a) values correlated significantly (P<0.05) with systolic blood pressure (SBP), diastolic blood pressure (DBP) and the main parameters of the lipid profile. We conclude that elevated plasma Lp (a) levels were associated with hypertension and show significant correlation with lipid levels. However higher plasma concentrations of Lp (a), albeit with in the normal range, could be an independent risk factor for atherosclerosis, and could contribute towards increasing the risk for cardiovascular disease in persons with essential hypertension

Study of relationship between serum adenosine deaminase and lipid profile and type 2 diabetes mellitus

Abstract Introduction: Diabetes mellitus type characterized by high blood glucose level. Adenosine deaminase (ADA) is the enzyme which catalyses the irreversible deamination of adenosine to inosin blood glucose and lipid profile in patients with uncomplicated type also to know any correlation between plasma glucose valu conducted in Dept. of Obstetrics and Gynaecology, MNR Medical College and Hospital, Sangareddy, Medak. We took total 50 patients in our study, out of which 25 patients were with uncomplicated type were as healthy control group. Blood sample were taken and Adenosine deaminase levels were measured colourimetrically, based on the method described by Giusti and Galanti. Other routine investigation like profile, Blood urea, Serum creatinine were also measured. patients as compared to controls and also strong correlations were found between serum ADA, lipid profile and plasma glucose levels. Conclusions: level is an indirect expression of tissue adenosine levels. In pathophysiology of diabetes, ADA has its multimetabolic effects

Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects

Context: Most of the information on remission related factors in Grave's disease are derived from Western literature. It is likely that there may be additional prognostic factors and differences in the postdrug treatment course of Grave's disease in India. Aim: To study factors which predict remission/relapse in Grave's disease patients from South India. Also to establish if technetium (Tc) uptake has a role in predicting remission. Subjects and Methods: Records of 174 patients with clinical, biochemical, and scintigraphic criteria consistent with Grave's disease, seen in our Institution between January 2006 and 2014 were analyzed. Patient factors, drug-related factors, Tc-99m uptake and other clinical factors were compared between the remission and nonremission groups. Statistical Analysis Used: Mann–Whitney U-test and Chi-square tests were used when appropriate to compare the groups. Results: Fifty-seven (32.7%) patients attained remission after at least 1 year of thionamide therapy. Of these, 11 (19.2%) patients relapsed within 1 year. Age, gender, goiter, and presence of extrathyroidal manifestations were not associated with remission. Higher values of Tc uptake were positively associated with remission (P- 0.02). Time to achievement of normal thyroid function and composite dose: Time scores were significantly associated with remission (P - 0.05 and P - 0.01, respectively). Patients with lower FT4 at presentation had a higher chance of remission (P - 0.01). The relapse rates were lower than previously reported in the literature. A higher Tc uptake was found to be significantly associated with relapse also (P - 0.009). Conclusion: The prognostic factors associated with remission in Graves's disease in this South Indian study are not the same as that reported in Western literature. Tc scintigraphy may have an additional role in identifying people who are likely to undergo remission and thus predict the outcome of Grave's disease

Health-related quality of life using QOLIE-31: Before and after epilepsy surgery a prospective study at a tertiary care center

Background: Outcome following epilepsy surgery has traditionally been measured in terms of relief of seizures. However, changes in health-related quality of life (HRQOL) after surgery for intractable epilepsy are also important to document. There are no studies on the Indian population which assess the outcome of epilepsy surgery in terms of HRQOL. Materials and Methods: We conducted a prospective study on the patients undergoing epilepsy surgery for intractable seizures, between February 2004 and May 2006 at our center. All patients cleared for epilepsy surgery by the epilepsy surgery team were taken up for study. All patients < 15 years age and mentally retarded or with progressive neurological diseases were excluded. Demographic profile, seizure characteristics and seizure outcome using Engel grading was assessed. Health-related quality of life was assessed using QOLIE-31 questionnaire before surgery and six months after surgery. Results: Thirty-six patients satisfying the inclusion/exclusion criteria were included in the analysis. Twenty-nine of these (Group 1) had good seizure outcome (Engel 1 and 2), while seven patients (Group 2) had poor seizure outcome (Engel 3 and 4) at six months. Overall, 77% of all study patients were completely seizure-free at follow-up. There was no baseline difference in the seven domains of QOLIE-31 between the two groups. There was very significant improvement ( P value> 0.005 using paired sample T test) in all the domains of QOLIE-31 in the good outcome group after surgery. Health-related quality of life improvement was seen in all the domains in the poor outcome group also, however, it was statistically significant only for the following parameters: seizure worry, overall QOL, emotional wellbeing, energy fatigue and social functioning domains. Improvement in seizure worry, overall QOL, emotional wellbeing and social functioning was significantly more in Group 1 as compared to Group 2. Conclusion: Complete seizure-free state after surgery is associated with very significant improvement in HRQOL parameters. Several, but not all parameters of HRQOL as assessed by QOLIE-31, improved after surgery even in the poor seizure outcome group. The improvement in domains of seizure worry, overall QOL, emotional wellbeing and social functioning is significantly more in those patients in whom complete seizure-free state is achieved